ARTICLE | Clinical News
SOR-C13: Phase I data
February 29, 2016 8:00 AM UTC
Top-line data from 22 evaluable patients with advanced solid tumors commonly known to express the TRPV6 channel and who failed all previous anticancer treatments in an open-label, North American Phase...